sector medic suppli devic
visibl growth remain
messag perform better mani investor
fear judg today stock reaction vs
still character fourth consecut quarter slow top-lin growth somewhat
concern particularli regard sharp deceler hr-pci case
lower revenu forecast bottom end manag guidanc rang
moder growth assumpt beyond continu view
impella under-penetrated within core indic use expect question
sustain top-lin growth trajectori limit upsid stock visibl
model call adjust ep yoy total revenu
cc compar prior forecast ep
sale revis revenu forecast low end manag guidanc
rang line cfo todd trapp comment morn call stock
react posit lower bar today initi feedback investor suggest us
concern compani abil achiev even reduc target like
persist see result incom statement project full year
oper margin yoy high end compani
sustain growth rate like remain key topic debat believ
signific question remain path forward compani growth
potenti beyond share current trade ntm sale
estim level commensur top-lin trajectori vs manag
guid growth rate forecast
result expect stock difficult time sustain posit momentum
visibl long-term growth trajectori improv investor expect
recalibr new normal remain neutral rate
page analyst certif import disclosur
leader mechan circulatori support dedic enabl safer
treatment high-risk patient cardiovascular diseas recov injur heart
muscl estim patient receiv one compani famili impella
heart pump last year yet believ scratch surfac impella
long-term potenti estim market opportun includ
impella smallest heart pump world design provid temporari
hemodynam support patient undergo high-risk procedur whose cardiac
function compromis sinc impella first receiv approv
impella famili pump use support ten thousand peopl
abiom revenu grow compound-annual-growth-rate period howev think third
straight quarter disappoint us impella growth make increasingli like
busi transit earli adopt phase flatter part penetr
curv believ manag take right step drive deeper penetr
chang like take time effect
share trade ntm revenu estim high end multipl
rang high-growth peer smid-cap med-tech group view multipl
commensur top line growth trajectori manag
guid result expect stock difficult time
sustain posit momentum visibl improv signific near-term
catalyst outsid quarterli earn report horizon see better opportun
elsewher maintain neutral rate
upsid risk rate includ potenti impella adopt exceed street
expect pipelin advanc improv long-term outlook failur
competit materi potenti larg player bring abiom
downsid risk rate includ potenti impella adopt fall short
street forecast pipelin setback clinic failur weaken abiom long-term
outlook faster-than-expect progress potenti impella competitor
premium valuat leav littl margin error view
page analyst certif import disclosur
million usd except
good sold
compani report guggenheim secur llc estim
page analyst certif import disclosur
million usd
servic
revenu geographi
 unit
 unit indic
compani report guggenheim secur llc estim
page analyst certif import disclosur
